Arterra Bioscience Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 38

Employees

  • Stock Symbol
  • ARBS

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $3.10
  • (As of Friday Closing)

Arterra Bioscience General Information

Description

Arterra Bioscience SpA is an Italian biotechnology company developing technologies and solutions for use across various sectors, including cosmetics, pharmaceuticals, agriculture, nutraceuticals, and food, among others. The company has developed cell screening and other technology platforms and offers a range of ingredients and active ingredients, such as NC75 Vita Tech Collagen, NC77 Vita Vinea, NC78 Vita Sculptis, and others, which are often used as raw materials in end-use cosmetics, pharmaceuticals, and other products. It generates maximum revenue from selling ingredients and active ingredients as raw materials to its clients in the cosmetics industry. Geographically, the company generates maximum revenue from its business in Italy.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Via Benedetto Brin, 69
  • 80142 Naples
  • Italy
+39 081
Primary Industry
Discovery Tools (Healthcare)
Stock Exchange
MIL
Corporate Office
  • Via Benedetto Brin, 69
  • 80142 Naples
  • Italy
+39 081

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arterra Bioscience Stock Performance

As of 20-Nov-2026, Arterra Bioscience’s stock price is $3.10. Its current market cap is $20.2M with 6.51M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.10 $3.19 $2.99 - $4.08 $20.2M 6.51M 4.6K $0.30

Arterra Bioscience Financials Summary

As of 30-Jun-2026, Arterra Bioscience has a trailing 12-month revenue of $6.03M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 20,260 19,468 10,098 5,895
Revenue 6,031 5,307 4,516 3,610
EBITDA 2,603 2,517 2,069 1,895
Net Income 1,940 2,263 1,446 1,164
Total Assets 16,679 17,135 13,946 13,878
Total Debt 272 306 371 427
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Arterra Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arterra Bioscience‘s full profile, request access.

Request a free trial

Arterra Bioscience Patents

Arterra Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3897683-A1 Cosmetic, pharmaceutical and nutraceutical use of an extract derived from cannabis sativa cell cultures Active 20-Dec-2018
EP-3897683-B1 Cosmetic, pharmaceutical and nutraceutical use of an extract derived from cannabis sativa cell cultures Active 20-Dec-2018
ES-2937391-T1 Cosmetic, pharmaceutical and nutraceutical use of an extract derived from cannabis sativa cell cultures Active 20-Dec-2018
ES-2937391-T3 Cosmetic, pharmaceutical and nutraceutical use of an extract derived from cannabis sativa cell cultures Active 20-Dec-2018
WO-2020127056-A1 Cosmetic, pharmaceutical and nutraceutical use of an extract derived from cannabis sativa cell cultures Inactive 20-Dec-2018 A61K36/3482
To view Arterra Bioscience’s complete patent history, request access »

Arterra Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arterra Bioscience Investments (3)

Arterra Bioscience’s most recent deal was a Joint Venture with Longevity Bioscience. The deal was made on 03-Sep-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Longevity Bioscience 03-Sep-2024 Joint Venture Other Pharmaceuticals and Biotechnology
ADL Farmaceutici 25-Jun-2021 Corporate Pharmaceuticals
Vitalab 01-Jan-2010 Joint Venture Other Commercial Products
To view Arterra Bioscience’s complete investments history, request access »

Arterra Bioscience ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Arterra Bioscience’s complete esg history, request access »

Arterra Bioscience Exits (1)

Arterra Bioscience’s most recent exit was on 03-Sep-2024 from Longevity Bioscience. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Longevity Bioscience 03-Sep-2024 Completed
  • 2 buyers
To view Arterra Bioscience’s complete exits history, request access »

Arterra Bioscience FAQs

  • When was Arterra Bioscience founded?

    Arterra Bioscience was founded in 2004.

  • Where is Arterra Bioscience headquartered?

    Arterra Bioscience is headquartered in Naples, Italy.

  • What is the size of Arterra Bioscience?

    Arterra Bioscience has 38 total employees.

  • What industry is Arterra Bioscience in?

    Arterra Bioscience’s primary industry is Discovery Tools (Healthcare).

  • Is Arterra Bioscience a private or public company?

    Arterra Bioscience is a Public company.

  • What is Arterra Bioscience’s stock symbol?

    The ticker symbol for Arterra Bioscience is ARBS.

  • What is the current stock price of Arterra Bioscience?

    As of 20-Nov-2026 the stock price of Arterra Bioscience is $3.10.

  • What is the current market cap of Arterra Bioscience?

    The current market capitalization of Arterra Bioscience is $20.2M.

  • What is Arterra Bioscience’s current revenue?

    The trailing twelve month revenue for Arterra Bioscience is $6.03M.

  • What is Arterra Bioscience’s annual earnings per share (EPS)?

    Arterra Bioscience’s EPS for 12 months was $0.30.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process